Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
5.
Pathologe ; 41(4): 406-410, 2020 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-32472158

RESUMO

Proliferative changes seen in reactive mesothelial hyperplasia of a hydrocele sac may mimic malignant mesothelioma. There is no immunohistochemical staining that reliably separates benign from malignant mesothelial proliferations. However, the combined analysis of BAP1 by immunohistochemistry and CDKN2A by FISH has been reported to yield both a high specificity and sensitivity in this differential diagnosis. In addition, the evaluation of risk factors such as asbestos exposure or prior traumata may be helpful for the correct diagnosis. Exclusion of stromal invasion, which is diagnostic for malign mesothelioma, is of utmost importance. Therefore, extended histological workup is essential.


Assuntos
Neoplasias Pulmonares , Mesotelioma , Neoplasias Testiculares , Proliferação de Células , Diagnóstico Diferencial , Humanos , Imuno-Histoquímica , Neoplasias Pulmonares/diagnóstico , Masculino , Mesotelioma/diagnóstico , Neoplasias Testiculares/patologia , Testículo , Proteínas Supressoras de Tumor/análise , Ubiquitina Tiolesterase/análise
6.
Pathologe ; 34(4): 305-9, 2013 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-23503854

RESUMO

BACKGROUND: Definitive diagnosis of unclear pulmonary lesions is mainly based on morphological methods. In addition to a neoplasm, inflammatory reactions, in particular tuberculosis (TB), have to be considered in most cases. Therefore, the aim of this work was to determine whether established methods used in general pathology can be efficiently used with cytological material. MATERIALS AND METHODS: An established polymerase chain reaction (PCR) protocol for the detection of Mycobacterium tuberculosis complex (Mtc) DNA in fixed specimens was conducted on fixed material available as an assay for liquid-based cytology (LBC). CytoLyt®-fixed material of 45 patients with clinically suspected TB or other mycobacteriosis were selected and were initially tested cytologically. In cases of absent tumor cells, PCR for detection of Mtc DNA and Ziehl-Neelsen stain (ZN) were performed. RESULTS: In 9 patients (20 %), Mtc DNA was found by PCR. The following methods were used to obtain material: catheter biopsy (5), needle biopsy (2), transbronchial needle aspiration (1), and bronchoalveolar lavage (1). Cytologically an inflammatory reaction was observed in all cases. In 2 patients, a history of TB, in 2 further cases either silicosis or a posttransplant situation was known. In cases with a positive PCR, 7 patients (78 %) were positive in ZN and 3 patients (33.3 %) in TB culture (15.5 % vs. 6.7 % of the total cohort); however, the material used for investigation was not always from identical sources, respectively. In 36 out of 45 patients, both PCR and ZN were negative for the detection of Mtc DNA. CONCLUSION: The material intended for LBC can be used for detection of TB with ZN and Mtc PCR.


Assuntos
Corantes , Reação em Cadeia da Polimerase/métodos , Tuberculose Pulmonar/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Técnicas Bacteriológicas , Biópsia , DNA Bacteriano/análise , DNA Bacteriano/genética , Diagnóstico Diferencial , Feminino , Humanos , Pulmão/patologia , Masculino , Pessoa de Meia-Idade , Mycobacterium tuberculosis/genética , Valor Preditivo dos Testes , Tuberculose Pulmonar/microbiologia
7.
Pathologe ; 34(2): 94-104, 2013 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-23423505

RESUMO

Esophageal malformations are rare and can occur sporadically or as a component of various syndromes. The variations and classifications are manifold. With the available modern operation techniques most malformations can be resolved with good results. However, esophageal malformations are often combined with further malformations which limit the prognosis. The separation of the trachea and esophagus after gastrulation is not yet completely researched. The results so far indicate that the localized expression of various homeodomain transcription factors is essential for normal development of the trachea and esophagus.


Assuntos
Esôfago/anormalidades , Esôfago/patologia , Anastomose Cirúrgica , Doenças em Gêmeos/diagnóstico , Doenças em Gêmeos/genética , Doenças em Gêmeos/patologia , Doenças em Gêmeos/cirurgia , Divertículo Esofágico/diagnóstico , Divertículo Esofágico/genética , Divertículo Esofágico/patologia , Divertículo Esofágico/cirurgia , Atresia Esofágica/diagnóstico , Atresia Esofágica/genética , Atresia Esofágica/patologia , Atresia Esofágica/cirurgia , Esôfago/embriologia , Esôfago/cirurgia , Feminino , Loci Gênicos/genética , Humanos , Lactente , Recém-Nascido , Masculino , Fenótipo , Prognóstico , Síndrome , Traqueia/anormalidades , Traqueia/embriologia , Traqueia/patologia , Traqueia/cirurgia , Fístula Traqueoesofágica/diagnóstico , Fístula Traqueoesofágica/genética , Fístula Traqueoesofágica/patologia , Fístula Traqueoesofágica/cirurgia
8.
Pathologe ; 34(4): 338-42, 2013 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-23263441

RESUMO

Benign epithelial tumors of the tracheobronchial system and the lungs are exceedingly rare. These entities encompass squamous and glandular papillomas (as well as their mixed forms) and adenomas (alveolar adenoma, papillary adenoma, salivary gland-like pleomorphic and mucinous adenomas and mucinous cystadenomas). These tumors are considered to be biologically benign neoplasms; however, they can pose considerable diagnostic difficulties, especially during frozen section evaluation, as they can mimic malignant tumors and in particular they can resemble well differentiated papillary adenocarcinomas. As a result of the extreme rarity of these tumors only a few descriptive diagnostic series exist and a systematic investigation including molecular data does not exist. This article presents the case of a 64-year-old patient with a glandular papilloma of the right main bronchus including the immunohistochemical and molecular work-up as well as a review of the current literature.


Assuntos
Neoplasias Brônquicas/genética , Neoplasias Brônquicas/patologia , Éxons/genética , Mutação/genética , Papiloma/genética , Proteínas Proto-Oncogênicas/genética , Proteínas ras/genética , Adenocarcinoma Papilar/genética , Adenocarcinoma Papilar/patologia , Substituição de Aminoácidos/genética , Asparagina/genética , Brônquios/patologia , Brônquios/cirurgia , Neoplasias Brônquicas/cirurgia , Broncoscopia , Diagnóstico Diferencial , Receptores ErbB/genética , Feminino , Secções Congeladas , Glicina/genética , Humanos , Pessoa de Meia-Idade , Papiloma/patologia , Papiloma/cirurgia , Pneumonectomia , Proteínas Proto-Oncogênicas p21(ras) , Análise de Sequência de DNA , Proteína Supressora de Tumor p53/genética
9.
Pathologe ; 33(4): 308-15, 2012 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-22752354

RESUMO

Endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TBNA) has become an important tool in the diagnosis and staging of malignant tumors of the lungs and mediastinum. Rapid on-site evaluation (ROSE) denotes a cytomorphological diagnostic procedure that allows assessment of the adequacy and accuracy of the material obtained during bronchoscopy within a few minutes in or near the bronchoscopy suite (on-site) using a quick staining of smears. This results in a significant decrease in the number of repeated bronchoscopy procedures required to recover an adequate biopsy sample and is therefore both time and cost effective. The obtained material can be further assessed as conventional cytological specimens or alternatively using the thin-prep technique for definitive cytopathology diagnosis and/or embedded in paraffin for immunohistochemical or molecular analyses such as DNA sequencing or flow cytometry.


Assuntos
Neoplasias Pulmonares/patologia , Neoplasias do Mediastino/patologia , Algoritmos , Biópsia por Agulha Fina/instrumentação , Biópsia por Agulha , Broncoscopia/instrumentação , Técnicas Citológicas/métodos , Desenho de Equipamento , Humanos , Pulmão/patologia , Neoplasias Pulmonares/diagnóstico por imagem , Metástase Linfática/patologia , Neoplasias do Mediastino/diagnóstico por imagem , Mediastinoscopia , Estadiamento de Neoplasias , Valor Preditivo dos Testes , Estudos de Tempo e Movimento , Tomografia Computadorizada por Raios X , Ultrassonografia de Intervenção/instrumentação
10.
Pathologe ; 33(3): 175-82, 2012 May.
Artigo em Alemão | MEDLINE | ID: mdl-22576594

RESUMO

Left ventricular assist devices (LVAD) are currently used to treat patients with terminal congestive heart failure as a bridge to transplantation or as destination therapy in individuals with contraindications for cardiac transplantation. The LVADs are pulsatile or non-pulsatile systems that transport blood from the left ventricle to the ascending aorta parallel to the circulation thus providing a profound volume and pressure reduction in the left ventricle. The use of LVADs is associated with a considerable decrease of cardiac hypertrophy and dilation with significantly improved cardiac performance in a small subset of patients. The underlying process is termed reverse cardiac remodelling and is characterized by a significant decrease in the size of cardiomyocytes and reversible regulation of numerous molecular systems in the myocardium.


Assuntos
Insuficiência Cardíaca/patologia , Insuficiência Cardíaca/terapia , Coração Auxiliar , Miocárdio/patologia , Regeneração/fisiologia , Pressão Sanguínea/fisiologia , Volume Sanguíneo/fisiologia , Tamanho Celular , Replicação do DNA/fisiologia , Matriz Extracelular/fisiologia , Humanos , Mediadores da Inflamação/fisiologia , Miócitos Cardíacos/patologia , Peptídeos Natriuréticos/fisiologia , Complexo de Endopeptidases do Proteassoma/fisiologia , Receptores Adrenérgicos beta/fisiologia , Sistema Renina-Angiotensina/fisiologia , Transdução de Sinais/fisiologia , Células-Tronco/patologia , Ubiquitina/fisiologia
12.
Pathologe ; 32(2): 104-12, 2011 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-21424408

RESUMO

Lung transplantation is the ultimate therapeutical approach for the treatment of both children and adults with terminal congenital or acquired lung disease. In contrast to survival rates during the first year following transplantation, the long-term survival for patients after lung transplantation has not significantly improved in the past. In addition to other complications, acute cellular rejection constitutes a major cause for diminished function of pulmonary grafts, and can, among other factors, be causative for chronic rejection (bronchiolitis obliterans syndrome, BOS). In 2006, the International Society for Heart and Lung Transplantation (ISHLT) provided a revised version of the grading system for acute and chronic rejection of pulmonary grafts.


Assuntos
Rejeição de Enxerto/patologia , Transplante de Pulmão/patologia , Adulto , Biópsia , Bronquiolite Obliterante/classificação , Bronquiolite Obliterante/imunologia , Bronquiolite Obliterante/mortalidade , Bronquiolite Obliterante/patologia , Criança , Rejeição de Enxerto/classificação , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/mortalidade , Teste de Histocompatibilidade , Humanos , Imunidade Celular/imunologia , Imunossupressores/uso terapêutico , Leucócitos/imunologia , Leucócitos/patologia , Pulmão/imunologia , Pulmão/patologia , Transplante de Pulmão/imunologia , Prognóstico , Fatores de Risco , Taxa de Sobrevida , Imunologia de Transplantes/imunologia
13.
Pathologe ; 32(2): 95-103, 2011 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-21305380

RESUMO

Since the first heart transplantation in 1967, the procedure has become an established therapy in the treatment of terminal heart failure. Constant advances in the development of potent immunosuppressive drugs, as well as greater clinical experience and pathological diagnostics have improved patient survival dramatically. The first grading system for rejection was published in 1990 by the International Society for Heart and Lung Transplantation (ISHLT) and revised in 2004. The 2004 grading system comprises three grades of severity (1R, 2R, 3R), whereby the former grade 2 in the 1990 system has been incorporated in the new grade 1R. Recommendations are made for the histological diagnosis of acute antibody-mediated rejection using immunohistochemical staining against C4d and macrophages. To the present day, the pathological examination of endomyocardial biopsies remains the gold standard for post-transplant diagnostic procedures. Whether or not non-invasive diagnostic approaches (e.g. gene array profile analysis on leukocytes) can replace morphological investigations needs to be clarified in randomised, prospective clinical studies.


Assuntos
Rejeição de Enxerto/patologia , Insuficiência Cardíaca/cirurgia , Transplante de Coração/patologia , Biópsia , Endocárdio/imunologia , Endocárdio/patologia , Endotélio Vascular/imunologia , Endotélio Vascular/patologia , Eosinófilos/imunologia , Eosinófilos/patologia , Rejeição de Enxerto/classificação , Rejeição de Enxerto/imunologia , Insuficiência Cardíaca/patologia , Transplante de Coração/imunologia , Humanos , Imunidade Celular/imunologia , Linfócitos/imunologia , Linfócitos/patologia , Miocárdio/imunologia , Miocárdio/patologia , Miócitos Cardíacos/imunologia , Miócitos Cardíacos/patologia , Plasmócitos/imunologia , Plasmócitos/patologia , Imunologia de Transplantes/imunologia
14.
Pathologe ; 31(5): 355-60, 2010 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-20809404

RESUMO

The staging system for lung tumours is now recommended for the classification of both non-small-cell and small-cell lung cancer as well as for carcinoid tumours of the lung. The T classifications have been redefined: T1 has been subclassified as T1a (≤ 2 cm in size) and T1b (> 2-3 cm in size). T2 has been subclassified as T2a (> 3-5 cm in size) and T2b (> 5-7 cm in size). T2 (> 7 cm in size) has been reclassified as T3. Multiple tumour nodules in the same lobe have been reclassified from T4 to T3. Multiple tumour nodules in the same lung but a different lobe have been reclassified from M1 to T4. No changes have been made in the N classification. The M classification has been redefined: M1 has been subdivided into M1a and M1b. Malignant pleural and pericardial effusions have been reclassified from T4 to M1a. Separate tumour nodules in the contralateral lung have been reclassified from T4 to M1a. M1b designates distant metastasis.


Assuntos
Tumor Carcinoide/patologia , Carcinoma Pulmonar de Células não Pequenas/patologia , Carcinoma de Células Pequenas/patologia , Neoplasias Pulmonares/patologia , Estadiamento de Neoplasias/métodos , Tumor Carcinoide/classificação , Carcinoma Pulmonar de Células não Pequenas/classificação , Carcinoma de Células Pequenas/classificação , Progressão da Doença , Humanos , Pulmão/patologia , Neoplasias Pulmonares/classificação , Metástase Linfática/patologia , Invasividade Neoplásica/patologia , Neoplasias Primárias Múltiplas/classificação , Neoplasias Primárias Múltiplas/patologia , Derrame Pleural Maligno/patologia
15.
Artigo em Inglês | MEDLINE | ID: mdl-17409785

RESUMO

Cholesteatomas show histomorphological features like papillary growth and koilocytosis, which are characteristic of lesions induced by human papillomaviruses (HPV). Two previous studies investigating the possible role of HPV in the development of cholesteatoma had detected HPV-6 and HPV-11 DNA with a prevalence differing from 3 to 36%. The aim of the presented study was to evaluate the prevalence of different HPV types in cholesteatomas using a sensitive detection system for HPV DNA. Twenty-nine biopsies from cholesteatomas were screened for HPV DNA with a 2-step broad-spectrum PCR (PCR and nested PCR). HPV-positive products were directly sequenced by means of a cycle sequencing approach. Sensitivity of the applied broad-spectrum PCR was 0.1 copy/genome. One out of 29 biopsies showed a positive signal on the nested PCR level. Considering the low prevalence (1/29 biopsies) of detected HPV DNA in cholesteatomas, infections with common HPV types are unlikely to be a causative factor.


Assuntos
Colesteatoma da Orelha Média , Infecções por Papillomavirus , Adolescente , Adulto , Idoso , Criança , Colesteatoma da Orelha Média/epidemiologia , Colesteatoma da Orelha Média/genética , Colesteatoma da Orelha Média/virologia , Primers do DNA/genética , DNA Viral/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/genética , Infecções por Papillomavirus/virologia , Reação em Cadeia da Polimerase , Prevalência
16.
Histopathology ; 46(1): 89-97, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15656891

RESUMO

AIMS: Eosinophilic heart syndromes are rare in Western countries and include endocarditis parietalis fibroplastica (EPF) and hypersensitivity myocarditis (HM). There are striking differences in natural history and morphological findings. Since diagnosis can be difficult when analysing small myocardial biopsies lacking the characteristic histological features, we studied a set of immunohistochemical markers in order to characterize the activation status of the infiltrating eosinophils to distinguish between these two entities. METHODS AND RESULTS: This study is based on the investigation of seven explanted hearts and one left ventricular specimen collected during implantation of a left ventricular assist device from a total of seven patients with HM. Also investigated were three right and three left ventricular specimens from five patients with EPF. We used antibodies (Ab) against EG1, and EG2, CD44, and CD69 which have been described as markers to distinguish between resting and activated eosinophils. The EG1 to EG2 ratio of eosinophils and the immunoreactivity against CD44 showed no differences between the two entities. However, eosinophils in the EPF were completely negative for CD69, whereas eosinophils reacted positively within the HM group. CONCLUSION: The immunohistochemical investigation of eosinophilic heart diseases using antibodies against CD69 can be a useful tool to distinguish between hypersensitivity myocarditis and endocarditis parietalis fibroplastica.


Assuntos
Eosinófilos/imunologia , Cardiopatias/imunologia , Imuno-Histoquímica , Idoso , Animais , Anticorpos Monoclonais/imunologia , Antígenos CD/imunologia , Antígenos de Diferenciação de Linfócitos T/imunologia , Diagnóstico Diferencial , Endocardite/diagnóstico , Endocardite/imunologia , Endocardite/patologia , Eosinófilos/patologia , Feminino , Cardiopatias/diagnóstico , Cardiopatias/patologia , Humanos , Lectinas Tipo C , Masculino , Camundongos , Pessoa de Meia-Idade , Miocardite/diagnóstico , Miocardite/imunologia , Miocardite/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA